Skip to content
NewsBlazeIN – Lifestyle
Author:
Deep Origin
Deep Origin’s Computational Platform Rationalizes Results of Molecular Glue Compound That Potently Kills Diffuse Large B Cell Lymphoma Cells
July 20, 2026
Tim Foley Joins Deep Origin as Chief Commercial Officer
March 31, 2026
Deep Origin Promotes Natalie Ma, PhD, to Chief Business Officer as Company Advances Computational Drug Discovery Platform
March 17, 2026